Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis

Fig. 1

Comparison of effectiveness between the Pre-MPZ and the Post-MPZ. a Remission rates. b BVAS. c VDI. d Eosinophil counts. e Concomitant CS doses. BVAS, Birmingham vasculitis activity score; CS, corticosteroid; VDI, vasculitis damage index. P values were determined by Wilcoxon signed-rank test. *P < 0.05: baseline (month 0) vs. each observation points (month 0,1, 3, 6, and 12)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us